Following a fresh round of job cuts in December, CDMO National Resilience is carrying its downsizing efforts into 2025. | ...
National Resilience acquired the Triangle office in 2021. Since then, funding for gene therapy solutions has fallen.
D.R. Horton (NYSE: DHI) recently paid $4.475 million for an office building on Meridian Parkway near Research Triangle Park, ...
ORLADEYO net revenue expected to be between $515-$535 million in 2025——Total revenue (including RAPIVAB®) expected to be between $540-$560 ...
National Reliance Inc., which focuses on biologics, vaccines, and gene therapies, is expected to keep the Triangle office open after the cuts.